Quarterly report pursuant to Section 13 or 15(d)

SEGMENT INFORMATION (Details)

v3.10.0.1
SEGMENT INFORMATION (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
Revenues $ 496,093 $ 374,751 $ 804,006 $ 441,037  
Depreciation 124,596 34,130 247,975 34,156  
Interest expenses 24,932 42,000 261,918 42,000  
Net income (loss) (1,343,815) (430,508) (2,894,784) (979,841) [1]  
Identifiable long-lived tangible assets 7,868,527   7,868,527   $ 7,671,786
Real property operating [Member]          
Revenues 278,872 222,254 575,495 222,254  
Depreciation 32,625 32,943 65,249 32,943  
Interest expenses 24,932 42,000 261,918 42,000  
Net income (loss) 5,617 (1,234) (232,083) (1,234)  
Identifiable long-lived tangible assets 7,745,277   7,745,277   7,645,371
Medical related consulting services [Member]          
Revenues 141,996 152,497 141,996 218,783  
Depreciation 3,991 1,187 7,997 1,213  
Interest expenses  
Net income (loss) 16,456 54,782 (157,018) (161,789)  
Identifiable long-lived tangible assets 12,507   12,507   20,558
Development services and sales of developed products[Member]          
Revenues 75,225 86,515  
Depreciation 87,980 174,729  
Interest expenses  
Net income (loss) (196,896) (297,028)  
Identifiable long-lived tangible assets 110,743   110,743   $ 5,857
Others [Member]          
Net income (loss) [1] $ (1,168,992) $ (484,056) $ (2,208,655) $ (816,818)  
[1] The Company does not allocate any general and administrative expense of its being a public company activities to its reportable segments as these activities are managed at a corporate level.